Cost- Effectiveness and Cost-utility of Laparoscopic Versus Open Repair of Ventral Hernia
1 other identifier
interventional
130
1 country
1
Brief Summary
The purpose of this prospective paper is to make a comparison between laparoscopic and opening approaches in ventral hernia repair, taking into account absence of recurrence in long - time (5 years), results centered at patient, especially satisfaction with expectations and improvement of normal physical activity, morbidity that particular form must include chronic pain, adjusted mortality through co-morbidities and, finally, prospective expenses, related to both effectiveness and utility
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jan 2005
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 24, 2013
CompletedFirst Posted
Study publicly available on registry
January 29, 2013
CompletedJanuary 29, 2013
January 1, 2013
3.9 years
January 24, 2013
January 25, 2013
Conditions
Outcome Measures
Primary Outcomes (2)
Cost-effectiveness
As effectiveness measure a clinic profit analysis was carried out by means of a composite analysis that integrates absence of recurrence, readmission, reoperation or disability.
5 years
Cost-utility
As an indirect measure of utility is used values obtained from questionnaires (HRQOL -Health Related Quality Of Life), assuming standard mean response in case of SF-36 and mean response standardized by standard deviation of difference in case of CVP-CG instruments between two types of repairs as well as effect size between preoperative value and postoperative one in case of SF-36. choice of measurement of HRQOL as a measure of utility was made under requirement that in absence of clinically relevant differences in mortality, recurrence or morbidity, a clinically relevant difference in HRQOL is a preference by patient and thus a choice between treatment alternatives.
5 years
Study Arms (2)
Laparoscopic ventral hernia repair
ACTIVE COMPARATORLaparoscopic repair: Pneumoperitoneum was performed to 12 mmHg. Herniary contents and sac are reduced releasing adhesions with diathermy or harmonic scalpel. Defects are repaired with a polytetrafluoroethylene (PTFE) patch (Dual Mesh; W.L Gore and Associates, FlagstaV, AZ USA) with double crown fixation as technique of Carbajo et al, ensuring exceed 3 cm edge of defect, using 5mm tackers (Protack, Autosuture; Tyco Healthcare, USA), reducing intrabdominal pressure to 8 mmHg. All operations were performed by experienced surgeons, over than 40 laparoscopic ventral hernia repairs.
Open ventral hernia repair
PLACEBO COMPARATOROpen repair: Incision was made over hernia defect, reducing herniary contents by opening sac if it is necessary. We made 4 cm soft tissue flaps around edge of defect depending on available healthy fascial tissue. Chevrel technique with fascial closure using anterior rectus sheath with continuous and absorbable suture and placement of polypropylene mesh (Parietene standart polypropylene mesh, Covidien, Norwalk, CT) in an onlay position fixed with polypropylene suture.
Interventions
Intraperitoneal ventral hernia repair with the use of Gore-tex Patch
Eligibility Criteria
You may qualify if:
- Patients above 18 years old, diagnosed
- Primary or incisional ventral hernia (clinic and radiologic: abdominal wall CT scan), including recurrent ones,
- Hernia estimated size from 20 to 225 cm2.
You may not qualify if:
- Included type 4 or 5 of ASA (American Society of Anesthesiologist),
- Disease limiting lifespan to less than 2 years,
- Cirrhotic ascites,
- Emergency surgery
- intestinal obstruction,
- strangulated hernia,
- peritonitis,
- Local or systemic infection,
- failure of patient to ensure an at least 2 years follow-up or abandonment protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Infanta Elena
Huelva, 21005, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pedro Naranjo-Rodríguez, Dr
Surgery Dep. Complejo Hospitalario Huelva
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- General and Gastrointestinal Surgery
Study Record Dates
First Submitted
January 24, 2013
First Posted
January 29, 2013
Study Start
January 1, 2005
Primary Completion
December 1, 2008
Study Completion
December 1, 2012
Last Updated
January 29, 2013
Record last verified: 2013-01